During the past decade, Nerve and Muscle Center of Texas conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 9 clinical trials were completed, i.e. on average, 56.3% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 5 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Nerve and Muscle Center of Texas" #1 sponsor was "Helixmith Co., Ltd." with 4 trials, followed by "Sangamo Therapeutics" with 3 trials sponsored, "Mitsubishi Tanabe Pharma America Inc." with 2 trials sponsored, "University of Kansas Medical Center" with 2 trials sponsored and "ZevraDenmark" with 2 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Nerve and Muscle Center of Texas" #1 collaborator was "University College, London" with 2 trials as a collaborator, "University of Kansas Medical Center" with 2 trials as a collaborator, "Juvenile Diabetes Research Foundation" with 1 trials as a collaborator, "National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)" with 1 trials as a collaborator and "University of Missouri-Columbia" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Nerve and Muscle Center of Texas" are "Diabetic Neuropathy, Painful" (5 trials), "Amyotrophic Lateral Sclerosis" (4 trials), "Painful Diabetic Neuropathy" (4 trials), "ALS" (3 trials) and "Inclusion Body Myositis" (3 trials). Many other conditions were trialed in "Nerve and Muscle Center of Texas" in a lesser frequency.

Most popular intervention types in "Nerve and Muscle Center of Texas" are "Drug" (20 trials), "Other" (8 trials), "Biological" (6 trials) and "Genetic" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (14 trials), "SB-509" (3 trials), "Arimoclomol" (2 trials), "Engensis" (2 trials) and "MT-1186" (2 trials). Other intervention names were less common.

The vast majority of trials in "Nerve and Muscle Center of Texas" are 25 trials for "All" genders.

Currently, there are NaN active trials in "Nerve and Muscle Center of Texas". undefined are not yet recruiting, 4 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in Nerve and Muscle Center of Texas, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Nerve and Muscle Center of Texas, 0 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".